Comparison of dexmedetomidine to ropivacaine heavy in spinal anaesthesia in lower limb surgeries.

Comparison of dexmedetomidine as an adjuvant to ropivacaine heavy in spinal anaesthesia in lower limb surgeries.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042465

Enrollment

Registered

2022-05-11

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine 0.75% heavy: Ropivacaine 0.75% heavy with 0.1ml saline will been given through spinal anaesthesia in lower limb surgeries. Control Intervention1: Ropivacaine 0.75% heavy wit

Eligibility

Inclusion criteria

Inclusion criteria: patient posted for lower limb surgeries. Patient posted for lower limb surgeries under spinal anaesthesia. Patient with American Society Of Anaesthesiologists(ASA) class I and II.

Exclusion criteria

Exclusion criteria: Patient with ASA class III,IV,V. Non-consenting patients. Patient with pre-existing cardiac diseases Severe renal or hepatic dysfunction. Patient with known allergy to study drugs.

Design outcomes

Primary

Measure	Time frame
To study the time to two segment regression of block.Timepoint: 24 hours	—

Secondary

Measure	Time frame
1)To assess the time for need of resue postoperative analgesia in first 24 hours. 2)To compare hemodynamics of the patients.Timepoint: 24 hours	—

Countries

India

Contacts

Public ContactDrDurga Jethava

mahatma gandhi medical college and hospital

Kalpana2007.KV@gmail.com9588079916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026